Contact
Let’s build the next evidence gate.
We welcome focused conversations with clinicians and emergency-care teams, engineering and manufacturing partners, regulatory experts and long-term medical technology investors.
Collaborate
Choose the right conversation.
Please include your organisation, your role and the area you would like to work in. We reply with the relevant non-confidential material and a concrete next step.
Study design and investigators
Protocol development, airway safety, emergency-care workflows and clinical endpoints.
Device development
Ventilation, thermal systems, verification, manufacturing and human factors.
MDR and clinical strategy
Classification, intended purpose, risk management and evidence alignment.
Milestone financing
Long-term capital for engineering, safety work and prospective clinical evidence.
Contact details
Medical Cooling.
Ethicalsaving gUG
General enquiries: info@medicalcooling.com
Fabian Temme
Founder
fabian@ethicalsaving.org
+49 171 12 56 491
What we can send you
The investor deck · the business plan in bank-standard, development-bank and venture versions · the 2027–2031 financial model · the peer-reviewed publication, the Go-Bio final report and the ISMRM poster · our position paper on the German emergency-care reform. The deck is confidential and is shared directly.
AIRCHILL is a development-stage project. This website does not provide medical advice and does not offer an approved product for clinical sale.
Non-profit support
Medical Cooling is supported by Ethical Saving gUG.
Ethical Saving gUG supports Medical Cooling in building and developing AIRCHILL, and in the work towards reimbursement. It is a German gemeinnützige company — a charitable legal form whose purpose is fixed in its statutes and whose profits cannot be distributed to owners. That support is why work on an unanswered clinical question could continue through the years when it carried no commercial case.
It also covers the part no investor funds early. There is no reimbursement mechanism for a prehospital device in Germany: equipment is financed through the user charges of just under 300 emergency service districts, and there is no DRG-style payment. Establishing the health-economic case for that is slow, unglamorous and has no return — which is exactly what a charitable company is for.
Donations fund bench work, preclinical safety, study preparation, the reimbursement groundwork and the open publication of results, including the results that argue against us. A donation is not an investment. It buys no share, no return and no influence over what we publish.